Education
About Us
Working with TipRanks
Follow Us
Vincerx Pharma Inc (VINC)
NASDAQ:VINC
VINC Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.22 - $19.88
Previous CloseN/A
Volume2.27M
Average Volume (3M)N/A
Market Cap
$1.44M
Enterprise ValueN/A
Total Cash (Recent Filing)$10.09M
Total Debt (Recent Filing)$1.64M
Price to Earnings (P/E)―
Beta0.02
Next Earnings
May 08, 2025EPS Estimate
-3.4Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-19.56
Shares Outstanding5,234,000
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio-0.04
Price to Book (P/B)2.70
Price to Sales (P/S)2.42
P/FCF Ratio-0.04
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$2.00Price Target Upside614.29% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
Vincerx Pharma Inc News
Bulls Say, Bears Say
Bulls Say
Analyst PerspectiveAnalyst continues to have a positive view on VINC at current levels despite the challenges.
Clinical TrialsVIP943 has shown favorable safety and tolerability, with no dose-limiting toxicities reported in the 22 patients treated.
Bears Say
Financial PerformanceVINC ended with $10.1M in cash and equivalents, indicating limited financial resources.
Market GuidanceAnalyst is adjusting the price target to $2 from $4.
Strategic DependencyThe company continues to look for a partner to advance development of enitociclib and VIP236, suggesting dependency on external collaboration for progress.
Options Prices
Currently, No data available
---
Ownership Overview
75.01%
Insiders
4.07% Mutual Funds
0.03% Other Institutional Investors
20.66% Public Companies and
Individual Investors
VINC FAQ
What was Vincerx Pharma Inc’s price range in the past 12 months?
Vincerx Pharma Inc lowest stock price was $0.22 and its highest was $19.88 in the past 12 months.
What is Vincerx Pharma Inc’s market cap?
Vincerx Pharma Inc’s market cap is $1.44M.
When is Vincerx Pharma Inc’s upcoming earnings report date?
Vincerx Pharma Inc’s upcoming earnings report date is May 08, 2025 which is 59 days ago.
How were Vincerx Pharma Inc’s earnings last quarter?
Vincerx Pharma Inc released its earnings results on Apr 01, 2025. The company reported -$3.569 earnings per share for the quarter, missing the consensus estimate of -$3.4 by -$0.169.
Is Vincerx Pharma Inc overvalued?
According to Wall Street analysts Vincerx Pharma Inc’s price is currently Undervalued.
Does Vincerx Pharma Inc pay dividends?
Vincerx Pharma Inc does not currently pay dividends.
What is Vincerx Pharma Inc’s EPS estimate?
Vincerx Pharma Inc’s EPS estimate is -3.4.
How many shares outstanding does Vincerx Pharma Inc have?
Vincerx Pharma Inc has 5,234,000 shares outstanding.
What happened to Vincerx Pharma Inc’s price movement after its last earnings report?
Vincerx Pharma Inc reported an EPS of -$3.569 in its last earnings report, missing expectations of -$3.4. Following the earnings report the stock price went up 9.434%.
Which hedge fund is a major shareholder of Vincerx Pharma Inc?
Among the largest hedge funds holding Vincerx Pharma Inc’s share is Woodline Partners LP. It holds Vincerx Pharma Inc’s shares valued at 0.
Company Description
Vincerx Pharma Inc
Vincerx Pharma Inc. (VINC) is a clinical-stage biopharmaceutical company focused on developing innovative therapies to address unmet medical needs in oncology. The company primarily operates in the biotechnology sector, concentrating on a robust pipeline of targeted small molecules and antibody-drug conjugates designed to treat various forms of cancer. Vincerx's core strategy involves leveraging its deep scientific expertise to create novel treatment options that improve patient outcomes and quality of life.
Windtree Therapeutics
―
ReShape Lifesciences
―
Universe Pharmaceuticals
―
iSpecimen
―
Onconetix
―